SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-512383
Filing Date
2012-12-21
Accepted
2012-12-21 13:35:02
Documents
3
Period of Report
2012-12-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d457901d8k.htm 8-K 15878
2 CEO'S LETTER TO SHAREHOLDERS d457901dex991.htm EX-99.1 19728
3 GRAPHIC g457901image001.jpg GRAPHIC 31524
  Complete submission text file 0001193125-12-512383.txt   80483
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52062 | Film No.: 121280519
SIC: 2834 Pharmaceutical Preparations